A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol

Ruya Ozelsancak Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, TurkeyCorrespondence[email protected]

Ertugrul Erken Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey

Ismail Yildiz Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey

Semih Giray Department of Neurology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey

Tulin Yildirim Department of Radiology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey

Hasan Micozkadioglu Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey

REFERENCES

Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Ann Neurol. 1983;13(5):469–484.
PubMed Web of Science ®Google Scholar
Ueda J, Furukawa T, Takahashi S, Sakaguchi K. Elimination of ioversol by hemodialysis. Acta Radiol. 1996;37(5):826–829.
PubMedGoogle Scholar
Floriani I, Ciceri M, Torri V, Tinazzi A, Jahn H, Noseda A. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials. Invest Radiol. 1996;31(8):479–491.
PubMedGoogle Scholar
Muruve DA, Steinman TI. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency. Clin Nephrol. 1996;45(6):406–409.
PubMed Web of Science ®Google Scholar
Haley EC Jr. Encephalopathy following arteriography: A possible toxic effect of contrast agents. Ann Neurol. 1984;15(1):100–102.
PubMedGoogle Scholar
Torvik A, Walday P. Neurotoxicity of water-soluble contrast media. Acta Radiol Suppl. 1995;399:221–229.
PubMedGoogle Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date